Korean J Hematol.  2009 Mar;44(1):36-41. 10.5045/kjh.2009.44.1.36.

Effect of Platelet Transfusion on the Platelet Parameters of Recipient

• Lim YA
• Cho SR

• KMID: 2252171
• DOI: http://doi.org/10.5045/kjh.2009.44.1.36

Abstract

BACKGROUND
Because the platelet parameters have recently been used as indicators for various clinical conditions, there is a need to accurately estimate the platelet parameters by using an automated hematology analyzer. The aim of this study was to investigate an effect of a platelet transfusion on such platelet parameters as the mean platelet volume (MPV), the platelet volume distribution width (PDW), the mean platelet component (MPC) and the platelet component distribution width (PCDW) in transfused patients.
METHODS
The study subjects were 25 patients who were admitted to the Department of Hematology & Oncology and they had been transfused with platelets. CD62P labeling was performed in the remaining portions of single donor platelets products (SDP) and the pooled platelet concentrates (PC) just before the SDP and PC were released. The platelet parameters were determined using the ADVIA 120 and the whole blood samples from the patients before the platelet transfusions and within 10~16 hours after the transfusion.
RESULTS
There were no significant difference of all the platelet parameters between the SDP (n=21) and the pooled PC (n=8). The MPC and PCDW of the SDP and the PC were significantly lower than those of the samples from the patients before transfusion. However, the PCDW of the samples from the patients after transfusion was significantly lower than that before transfusion.
CONCLUSION
Because platelet transfusions lower the value of the PCDW in patients, the laboratory staff and clinicians should be aware of this when interpreting the PCDW.

Keyword

Platelet transfusion; Platelet parameter; Platelet component distribution width

MeSH Terms

Blood Platelets
Hematology
Humans
Platelet Transfusion
Tissue Donors

Figure

• 

  Fig. 1. The correlation between platelet count in patients after transfusion and mean platelet volume (MPV) in patients before transfusion (A) or the expression of CD62P in platelet products (B).

Reference

References

1. Kim HK, Kim JE, Ham CK, Lee DS, Park S, Cho HI. Prognostic value of platelet indices as determined by ADVIA 120 in patients suspected of having disseminated intravascular coagulation. Int J Lab Hematol. 2008; 30:117–23.

2. Zuberi BF, Akhtar N, Afsar S. Comparison of mean platelet volume in patients with diabetes mellitus, impaired fasting glucose and non-diabetic subjects. Singapore Med J. 2008; 49:114–6.

3. Coban E, Adanir H, Bilgin D. The association of mean platelet volume levels with hypertensive retinopathy. Platelets. 2008; 19:115–8.

4. Ntaios G, Papadopoulos A, Chatzinikolaou A, et al. Increased values of mean platelet volume and platelet size deviation width may provide a safe positive diagnosis of idiopathic thrombocytopenic purpura. Acta Haematol. 2008; 119:173–7.

5. Ihara A, Matsumoto K, Kawamoto T, et al. Evaluation of platelet indexes in patients with aortic aneurysm. Pathophysiol Haemost Thromb. 2005; 34:269–73.

6. Macey MG, Carty E, Webb L, et al. Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system. Cytometry. 1999; 38:250–5.

7. Lim YA, Hyun BH. Evaluation of platelet parameters on the ADVIA 120 as the quality indicator for stored platelets. Clin Lab Haematol. 2002; 24:377–84.

8. Boos CJ, Beevers GD, Lip GY. Assessment of platelet activation indices using the ADVIATM 120 amongst ‘high-risk' patients with hypertension. Ann Med. 2007; 39:72–8.

9. Dastjerdi MS, Emami T, Najafian A, Amini M. Mean platelet volume measurement, EDTA or citrate? Hematology. 2006; 11:317–9.

10. Lim YA, Cho SR, Lee WG, Park JS, Kim SW. Change of platelet activation markers using flow cytometry in patients with hematology/oncology disorders after transfusion. Platelets. 2008; 19:328–34.

11. Brecher ME, ed. Technical manual. 15th ed.Bethesda, USA: American Association of Blood Banks;2005. p. 363.

12. Ness PM, Campbell-Lee SA. Single donor versus pooled random donor platelet concentrates. Curr Opin Hematol. 2001; 8:392–6.

13. de Vries RA, de Bruin M, Marx JJ, Hart HC, Van de Wiel A. Viability of platelets collected by apheresis versus the platelet-rich plasma technique: a direct comparison. Transfus Sci. 1993; 14:391–8.

14. Turner VS, Hawker RJ, Mitchell SG, Seymour Mead AM. Paired in vivo and in vitro comparison of apheresis and "recovered" platelet concentrates stored for 5 days. J Clin Apher. 1994; 9:189–94.

15. Arnold DM, Heddle NM, Kulczycky M, Carruthers J, Sigouin C, Blajchman MA. In vivo recovery and survival of apheresis and whole blood-derived platle-lets: a paired comparison in healthy volunteers. Transfusion. 2006; 46:257–64.

16. Van der Lelie J, Von dem Borne AK. Platelet volume analysis for differential diagnosis of thrombocytosis. J Clin Pathol. 1986; 39:129–33.

17. Michelson AD, Barnard MR, Hechtman HB, et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA. 1996; 93:11877–82.

18. Ruf A, Patscheke H. Flow cytometric detection of activated platelets: comparison of determining shape change, fibrinogen binding, and P-selectin expression. Semin Thromb Hemost. 1995; 21:146–51.

19. Berger G, Hartwell DW, Wagner DD. P-Selectin and platelet clearance. Blood. 1998; 92:4446–52.

20. Reed GL. Platelet secretion. Michelson AD, editor. Platelets. 1st ed.London, England: Academic Press;2006. p. 181–95.